Logotype for Definium Therapeutics Inc

Definium Therapeutics Inc (DFTX) AGM 2024 summary

Event summary combining transcript, slides, and related documents.

Logotype for Definium Therapeutics Inc

AGM 2024 summary

1 Feb, 2026

Opening remarks and agenda

  • Meeting called to order with rules of conduct outlined for orderly proceedings and shareholder participation.

  • Cautionary note issued regarding forward-looking statements and associated risks.

  • Executive officers and meeting officials introduced, including CEO, Chief Legal Officer, and scrutineer.

  • Quorum confirmed and meeting declared duly constituted for business.

Corporate governance

  • Voting procedures explained, with electronic ballots and proxy instructions detailed.

  • Only board-nominated directors eligible for election, with six nominees listed.

  • All nominees currently serve as directors and have consented to act.

  • KPMG LLP nominated as independent auditor for the next term.

Board and executive committee updates

  • No new director nominations received; board composition remains unchanged.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more